Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05805137
Other study ID # WW001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 20, 2023
Est. completion date December 31, 2023

Study information

Verified date April 2023
Source CutoSense Oy
Contact Atte Kekonen, M.Sc.
Phone +358407273627
Email atte.kekonen@cutosense.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the functionality of a new type of wound monitoring method and measurement system for monitoring healing of venous ulcers. The system is consisted of a wound dressing with electrodes (eDressing), a bioimpedance measurement device and a mobile phone application.


Description:

The technical principle of the monitoring method is based on the quasimonopolar bioimpedance measurement. The measurement system consists of a bioimpedance measuring device, a wound dressing with electrodes (eDressing) and a mobile application for use with a mobile phone. The electrode dressing is placed on top of a wound, in contact with the wound tissue. The other necessary dressing layers (such as absorbent dressings and compression bandages) are placed over the electrode dressing. The aim is to keep the electrode bandage on the wound for seven consecutive days. Other dressings can be changed when necessary. However, the electrode dressing can be removed and replaced whenever due to medical necessity. During a study subject visit, the bioimpedance measurement is made, the uppermost dressings are opened carefully and it is ensured that the wound condition is as expected. Upon the replacement of the electrode dressing, the wound is photographed and documented. The wound area is measured, and the findings are recorded. A maximum of 20 subjects (10 to 20 subjects) with venous ulcers will be recruited for the study. Adults with venous ulcer who are applicable for compression therapy treatment and whose wound(s) fit on the area of no larger than 5 x 5 cm and whose wounds are do excrete excessively can be recruited to the study. Previous surgical venous procedure is not an exclusion criteria for enrollment, but surgical procedure can not be performed during the study. A subject shall visit the clinic 2-3 times a week, according to the doctor's or study nurse's assessment. Wound healing is monitored until the wound re-epithelized (>90% of initial wound surface area) or maximum two months. Thus, there will be a maximum of 24 study visits per subject.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age at least 18 years - The subject has a chronic lower extremity ulcer with a primary etiology of venous insufficiency. The previous venous procedure is not an obstacle to the study - Compression therapy can be implemented - The wound has a maximum surface area of 5 x 5 cm and can fit in an area of 5 cm x 5 cm. The wound should be located above the ankle, on the skin area where the electrode dressing can be placed properly. - The wound is not deep with steep edges or cavity-like - The wound is not highly excreting - The wound can be expected to heal within two months (area reduced = 90% from baseline) - The subject gives consent to the study and commits to following the instructions of the medical staff Exclusion Criteria: - Clinical wound infection at the time of the study - The subject has an intravenous procedure within 2 months - Significant arterial circulatory disorder or adherence problem that prevents compression therapy - Subject movement 2-3 times a week during the study to the study site is difficult to arrange - Diagnosed epoxy resin allergy - Any other reasons of potential study subject non-compliance by the opinion of the investigator

Study Design


Related Conditions & MeSH terms


Intervention

Device:
WoundWatch wound management system
eDressing will be applied along with the compression therapy and the standard absorbing dressings. The subjects will be monitored using the WoundWatch wound management system. The subjects will have two to three study visits per week until the venous ulcer has healed (surface area has decreased at least 90%) or up to two months.

Locations

Country Name City State
Poland University Clinical Centre, Gdansk Gdansk

Sponsors (3)

Lead Sponsor Collaborator
CutoSense Oy Medical University of Gdansk, University Clinical Centre, Gdansk

Country where clinical trial is conducted

Poland, 

References & Publications (3)

Kekonen A, Bergelin M, Eriksson JE, Vaalasti A, Ylanen H, Kielosto S, Viik J. Bioimpedance method for monitoring venous ulcers: Clinical proof-of-concept study. Biosens Bioelectron. 2021 Apr 15;178:112974. doi: 10.1016/j.bios.2021.112974. Epub 2021 Jan 7. — View Citation

Kekonen A, Bergelin M, Eriksson JE, Vaalasti A, Ylanen H, Viik J. Bioimpedance measurement based evaluation of wound healing. Physiol Meas. 2017 Jun 22;38(7):1373-1383. doi: 10.1088/1361-6579/aa63d6. — View Citation

Kekonen A, Bergelin M, Johansson M, Kumar Joon N, Bobacka J, Viik J. Bioimpedance Sensor Array for Long-Term Monitoring of Wound Healing from Beneath the Primary Dressings and Controlled Formation of H2O2 Using Low-Intensity Direct Current. Sensors (Basel). 2019 May 31;19(11):2505. doi: 10.3390/s19112505. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Wound Status Index (WSI) vs. wound surface area Correlation analysis between the WSI and the wound surface area. The WSI is derived from the bioimpedance measurement results. From admission to discharge, up to 8 weeks.
See also
  Status Clinical Trial Phase
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Recruiting NCT02838784 - Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers N/A
Completed NCT02092870 - Adipose Derived Regenerative Cellular Therapy of Chronic Wounds Phase 2
Terminated NCT00847002 - Flexitouch Treatment for Venous Ulcers N/A
Completed NCT01858272 - Preliminary Testing of New Treatment for Chronic Leg Wounds Phase 1
Not yet recruiting NCT05877378 - Efficacy of PICO Single-use System in Chronic Ulcers N/A
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Terminated NCT01396304 - Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers Phase 4
Not yet recruiting NCT06007703 - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Completed NCT04046120 - Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers N/A
Terminated NCT04021316 - Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration N/A
Completed NCT05729334 - Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions N/A
Completed NCT03070938 - PuraPly™ Antimicrobial Wound Matrix and Wound Management N/A
Terminated NCT01853384 - Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers Phase 3
Completed NCT00558662 - Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers N/A
Completed NCT01750749 - Cell Therapy for Venous Leg Ulcers Pilot Study Phase 1
Completed NCT01327937 - A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers Phase 4
Completed NCT00820196 - A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study) Phase 2
Completed NCT00301496 - Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers N/A
Recruiting NCT05489588 - The GORE® VIAFORT Vascular Stent Iliofemoral Study N/A